RECOGNISING CLINICAL TRIALS AND THE PEOPLE BEHIND THE RESEARCH, NHMRC CEO signs off tenure with final co-presenter role at ACTA Trial of the Year Awards
With
Prof Christopher Reid, Board Chair
Australian Clinical Trials Alliance (ACTA)
Professor Steve Wesselingh, CEO
National Health and Medical Research Council (NHMRC)
Chandana Guha,
Australasian Kidney Trials Network
Dr Menglu Ouyang on behalf of Professor Craig Anderson
Australasian Stroke Trials Network with The George Institute for Global Health
Professor David Curtis
Australasian Leukaemia and Lymphoma Group
Delaine Smith
Chief Executive Officer
Australasian Leukaemia & Lymphoma Group
SEGMENT
Filmed in Sydney | August 2026
Australia’s clinical trials community came together to celebrate outstanding research and recognise the people and teams making a meaningful difference to healthcare at the 2026 ACTA Trial of the Year Awards.
Now in its 10th year, the awards continue to shine a light on investigator-led clinical trials and initiatives that are improving clinical practice, influencing healthcare policy and delivering better outcomes for patients across Australia and beyond.
This year’s awards showcased the breadth and strength of Australia’s clinical trials sector, with achievements recognised across six categories spanning clinical trials, statistics, health economics, implementation science, consumer involvement and clinical quality registries.
ACTA Chair, Professor Chris Reid, highlighted the contribution of the nominees and winners to the broader clinical trials community, noting the expertise, collaboration and commitment demonstrated through their work.
Since their establishment in 2016, the ACTA Trial of the Year Awards have provided an opportunity to recognise the impact of clinical research and celebrate the people behind the trials. The 2026 ceremony continued this tradition, highlighting the important role Australian researchers and collaborators play in advancing healthcare and improving the lives of patients.
Source: ACTA news story 19th August 2026 https://clinicaltrialsalliance.org.au/latest-news/celebrating-outstanding-achievements-in-clinical-trials/
-
Analogy of the system, rather than the ED front door
“The problem of blockages shows up in ambulance ramping and long wait times, but this is a complex issue requiring whole-of-health system solutions,” according to Professor Hugh Grantham, Chair of Emergency Medicine Foundation in an interview with Australian Health Journal.
-
The quest to create an Australian framework for a Palliative Care Pharmacist
Helen Stone is the State and Territory Manager SA & NT for the Pharmaceutical Society Australia. Her professional interests include palliative care, pharmacist professional services, mental health, leadership, and management.
She has recently led teams of pharmacists in innovative pharmacy practice models including in aged care, GP practice, palliative care and dementia support. This has contributed to the body of evidence for sustainable funding for embedded pharmacist roles in primary care and aged care settings.
-
MedTech Industry invited to NSW Parliament House
The inaugural NSW Parliament MedTech Showcase, hosted by The Hon Courtney Houssos MLC has highlighted the medical technology sector’s contribution to patient care, local manufacturing, jobs and the broader economy.
Speaking with the Australian Health Journal, Justin Foster, Associate Director of Advocacy and Government Relations at the Medical Technology Association of Australia (MTAA), said the event provided an important opportunity for industry and government to work together on shared priorities.
